SEC Form 4 · accession 0000911916-16-000689
CoLucid Pharmaceuticals, Inc. · CLCD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Linda C. Hogan
Officer — Head, Bus. Dev. and Strategy
Period of report
Nov 4, 2016
Accepted (ET)
Nov 7, 2016 · 4:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348649
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 4, 2016 | M | 185 | $7.56 | A | 185 | D | |
| Common StockF1 | Nov 4, 2016 | S | 185 | $28.95 | D | 0 | D | |
| Common Stock | Nov 7, 2016 | M | 1,677 | $10.00 | A | 1,677 | D | |
| Common StockF1,F2 | Nov 7, 2016 | S | 1,677 | $28.5212 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $7.56 | Nov 4, 2016 | M | 185 | D | — | Aug 4, 2025 | Common Stock | 185 | 6,112 | D |
| Stock Option (Right to Buy)F4 | $10.00 | Nov 7, 2016 | M | 1,677 | D | — | May 5, 2025 | Common Stock | 1,677 | 50,321 | D |
Explanation of responses
- F1Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Ms. Hogan on March 24, 2016.
- F2Represents the sale of 1,677 shares in multiple transactions, ranging in price from $28.50 to $28.60 per share, resulting in a weighted average sale price of $28.5212. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F3Options vest as follows: one-third of the shares vested on August 4, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service.
- F4Options vest as follows: 33% of the shares vested on May 5, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service.